LBO — ATRIUM MEDICAL CENTER
IRR: 20.9% | MOIC: 2.58x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
20.9%
IRR
2.58x
MOIC
$142.0M
Entry EV
$252.1M
Exit EV
$73.1M
Equity Invested
Sources & Uses
S&UTotal · $142.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $55.1M | 38.8% | |
| Sub Debt | $13.8M | 9.7% | |
| Equity | $73.1M | 51.5% | |
| Enterprise Value | $137.8M | 97.1% | |
| Transaction Fees | $4.1M | 2.9% | |
| Total Uses | $142.0M | 100.0% |
Interpretation
INTAt 2.58x MOIC and 20.9% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $24.0M |
| Exit Ev | $252.1M |
| Net Debt At Exit | $63.5M |
| Equity At Exit | $188.6M |
| Equity Invested | $73.1M |
| Total Value Created | $115.6M |
| Value From Growth | $107.3M |
| Value From Multiple | $6.9M |
| Value From Deleveraging | $5.5M |